Epitope mapping of cytochrome P4502D6 (CYP2D6) autoantigen in patients with chronic hepatitis C under α-interferon treatment.

被引：0
|
作者：
Dalekos, G [1 ]
Wedemeyer, H [1 ]
Obermayer-Straub, P [1 ]
Kayser, A [1 ]
Barut, A [1 ]
Frank, H [1 ]
Manns, M [1 ]
机构：
[1] Med Hsch Hannover, Dept Gastroenterol & Hepatol, Hannover, Germany
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1384
引用
收藏
页码：508A / 508A
页数：1
相关论文
共 50 条
  • [1] Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during α-interferon treatment
    Dalekos, GN
    Wedemeyer, H
    Obermayer-Straub, P
    Kayser, A
    Barut, A
    Frank, H
    Manns, MP
    JOURNAL OF HEPATOLOGY, 1999, 30 (03) : 366 - 375
  • [2] Cytochrome P4502D6 (CYP2D6) bioelectrode for fluoxetine
    Iwuoha, EI
    Wilson, A
    Howel, M
    Mathebe, NGR
    Montane-Jaime, K
    Narinesingh, D
    Guiseppi-Elie, A
    ANALYTICAL LETTERS, 2004, 37 (05) : 929 - 941
  • [3] Cellular epitope mapping of cytochrome P4502D6 in patients with autoimmune hepatitis
    Ma, Y
    Bogdanos, DP
    Williams, R
    Mieli-Vergani, G
    Vergani, D
    JOURNAL OF HEPATOLOGY, 2001, 34 : 212 - 212
  • [4] Cytochrome P4502D6: understanding an autoantigen
    Choudhuri, K
    MieliVergani, G
    Vergani, D
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 108 (03): : 381 - 383
  • [5] Inhibition of cytochrome P4502D6 (CYP2D6) by terbinafine (TER) in vitro.
    Abdel-Rahman, SM
    Marcucci, K
    Boge, T
    Gotschall, RR
    Kearns, GL
    Leeder, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 135 - 135
  • [6] The in vitro interaction of dexmedetomidine with human liver microsomal cytochrome P4502D6 (CYP2D6)
    Rodrigues, AD
    Roberts, EM
    DRUG METABOLISM AND DISPOSITION, 1997, 25 (05) : 651 - 655
  • [7] Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity:: Characterization of gene duplication events
    Gaedigk, A.
    Ndjountche, L.
    Divakaran, K.
    Bradford, L. DiAnne
    Zineh, I.
    Oberlander, T. F.
    Brousseau, D. C.
    McCarver, D. G.
    Johnson, J. A.
    Alander, S. W.
    Riggs, K. Wayne
    Leeder, J. Steven
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2007, 81 (02) : 242 - 251
  • [8] Accuracy of cytochrome P4502D6 (CYP2D6): Phenotype assignment from genotyping data.
    Gaedigk, A
    Gotschall, RR
    Forbes, NS
    Simon, SD
    Leeder, JS
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 139 - 139
  • [9] Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102: Structural studies on specific CYP2D6 substrate metabolism
    Lewis, DFV
    Eddershaw, PJ
    Goldfarb, PS
    Tarbit, MH
    XENOBIOTICA, 1997, 27 (04) : 319 - 339
  • [10] Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans
    A Gaedigk
    A Bhathena
    L Ndjountché
    R E Pearce
    S M Abdel-Rahman
    S W Alander
    L DiAnne Bradford
    J Steven Leeder
    The Pharmacogenomics Journal, 2005, 5 : 173 - 182
12345